| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$656,173 ) |
| | 2024 | 2023 | NOVAN INC | 4020 STIRRUP CREEK DR | DURHAM | NC | 27703-8970 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 002 | 4 | NIH | 9/5/2024 | -$1 |
| | 2024 | 2021 | NOVAN INC | 4020 STIRRUP CREEK DR | DURHAM | NC | 27703-8970 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 001 | 3 | NIH | 9/5/2024 | -$126,370 |
| | 2024 | 2020 | NOVAN INC | 4020 STIRRUP CREEK DR | DURHAM | NC | 27703-8970 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 000 | 2 | NIH | 9/5/2024 | -$529,802 |
|
| Issue Date FY: 2023 ( Subtotal = $1 ) |
| | 2023 | 2023 | NOVAN, INC. | 4020 STIRRUP CREEK DR STE 110 | DURHAM | NC | 27703 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 002 | 4 | NIH | 4/19/2023 | $1 |
| | 2023 | 2020 | NOVAN INC | 4020 STIRRUP CREEK DR | DURHAM | NC | 27703-8970 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 001 | 2 | NIH | 4/7/2023 | -$110,781 |
| | 2023 | 2019 | NOVAN INC | 4020 STIRRUP CREEK DR | DURHAM | NC | 27703-8970 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 000 | 1 | NIH | 4/7/2023 | $110,781 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | NOVAN, INC. | 4020 STIRRUP CREEK DR STE 110 | DURHAM | NC | 27703 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 000 | 3 | NIH | 5/24/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $126,370 ) |
| | 2021 | 2021 | NOVAN, INC. | 4105 HOPSON RD | MORRISVILLE | NC | 27560-9018 | WAKE | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 000 | 3 | NIH | 4/8/2021 | $126,370 |
| | 2021 | 2020 | NOVAN, INC. | 4020 STIRRUP CREEK DR STE 110 | DURHAM | NC | 27703 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 002 | 2 | NIH | 6/5/2021 | $110,781 |
| | 2021 | 2019 | NOVAN, INC. | 4020 STIRRUP CREEK DR STE 110 | DURHAM | NC | 27703 | DURHAM | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 001 | 1 | NIH | 6/5/2021 | -$110,781 |
|
| Issue Date FY: 2020 ( Subtotal = $997,413 ) |
| | 2020 | 2020 | NOVAN, INC. | 4105 HOPSON RD | MORRISVILLE | NC | 27560-9018 | WAKE | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 000 | 2 | NIH | 2/18/2020 | $997,413 |
|
| Issue Date FY: 2019 ( Subtotal = $223,131 ) |
| | 2019 | 2019 | NOVAN, INC. | 4105 HOPSON RD | MORRISVILLE | NC | 27560-9018 | WAKE | USA | R44AI143022 | Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women | 000 | 1 | NIH | 8/12/2019 | $223,131 |
|
| Issue Date FY: 2013 ( Subtotal = $0 ) |
| | 2013 | 2012 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43GM103011 | USE OF A NITRIC OXIDE-LOADED GEL TO IMPROVE HEALING OUTCOMES OF BURN INJURIES | 000 | 1 | NIH | 4/16/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $1,641,849 ) |
| | 2012 | 2012 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43GM103011 | USE OF A NITRIC OXIDE-LOADED GEL TO IMPROVE HEALING OUTCOMES OF BURN INJURIES | 000 | 1 | NIH | 9/20/2012 | $148,105 |
| | 2012 | 2012 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43AI096569 | NITRIC OXIDE-RELEASING INTRANASAL GEL TO DECOLONIZE BIOFILM-EMBEDDED S. AUREUS | 000 | 2 | NIH | 7/16/2012 | $292,972 |
| | 2012 | 2012 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R44AI074098 | NITRIC OXIDE-RELEASING WOUND DRESSING FOR PREVENTING CHRONIC WOUND INFECTIONS | 000 | 5 | NIH | 7/16/2012 | $711,729 |
| | 2012 | 2012 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43DK093119 | IMPROVING HOST RESPONSE TO IMPLANTABLE GLUCOSE SENSORS VIA NITRIC OXIDE RELEASE | 000 | 2 | NIH | 8/30/2012 | $489,043 |
|
| Issue Date FY: 2011 ( Subtotal = $1,789,812 ) |
| | 2011 | 2011 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R44AI074098 | NITRIC OXIDE-RELEASING WOUND DRESSING FOR PREVENTING CHRONIC WOUND INFECTIONS | 000 | 4 | NIH | 7/18/2011 | $991,948 |
| | 2011 | 2011 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43AI096569 | NITRIC OXIDE-RELEASING INTRANASAL GEL TO DECOLONIZE BIOFILM-EMBEDDED S. AUREUS | 002 | 1 | NIH | 9/22/2011 | $300,000 |
| | 2011 | 2011 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43AI096569 | NITRIC OXIDE-RELEASING INTRANASAL GEL TO DECOLONIZE BIOFILM-EMBEDDED S. AUREUS | 001 | 1 | NIH | 9/21/2011 | -$300,000 |
| | 2011 | 2011 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43DK093119 | IMPROVING HOST RESPONSE TO IMPLANTABLE GLUCOSE SENSORS VIA NITRIC OXIDE RELEASE | 000 | 1 | NIH | 8/16/2011 | $497,864 |
| | 2011 | 2011 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43AI096569 | NITRIC OXIDE-RELEASING INTRANASAL GEL TO DECOLONIZE BIOFILM-EMBEDDED S. AUREUS | 000 | 1 | NIH | 8/25/2011 | $300,000 |
| | 2011 | 2010 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43AI082866 | NITRIC OXIDE RELEASING CATHETER COATINGS TO PREVENT NOSOCOMIAL INFECTIONS | 000 | 1 | NIH | 5/20/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $1,247,422 ) |
| | 2010 | 2010 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43AI082866 | NITRIC OXIDE RELEASING CATHETER COATINGS TO PREVENT NOSOCOMIAL INFECTIONS | 000 | 1 | NIH | 5/4/2010 | $282,022 |
| | 2010 | 2010 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R44AI074098 | NITRIC OXIDE-RELEASING WOUND DRESSING FOR PREVENTING CHRONIC WOUND INFECTIONS | 000 | 3 | NIH | 6/17/2010 | $965,400 |
|
| Issue Date FY: 2009 ( Subtotal = $199,612 ) |
| | 2009 | 2009 | NOVAN INC | PO BOX 110023 | RESEARCH TRIANGLE PARK | NC | 27709 | DURHAM | USA | R43AI074098 | STTR PHASE 1: NITRIC OXIDE-RELEASING ANTIBACTERIAL WOUND DRESSING | 000 | 2 | NIH | 7/24/2009 | $199,612 |
|
| Issue Date FY: 2008 ( Subtotal = $199,992 ) |
| | 2008 | 2008 | NOVAN INC | 1227 HOLLY HILL DRIVE | DURHAM | NC | 27713 | DURHAM | USA | R43AI074098 | STTR PHASE 1: NITRIC OXIDE-RELEASING ANTIBACTERIAL WOUND DRESSING | 000 | 1 | NIH | 8/11/2008 | $199,992 |
|
|
